Project Details
| Status | Active |
|---|---|
| Effective start/end date | 6/4/18 → 8/31/50 |
Funding
- Regulus Therapeutics Inc.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, Pharmacodynamics, and Pharmacokinetics of RG012-03 for Injection Administered Every 2 Weeks in Patients with Alport Syndrome
- Langman, Craig (PD/PI)
Project: Research project